Pentapeptide-59(CAS: N/A)Sensitive Skin Care Peptide

PRODUCT PARAMETERS

Pentapeptide-59

CAS: N/A

Sensitive Skin Care / Soothing & Anti-Inflammatory

Pentapeptide-59: TRPV1 inhibitor from sea anemone. Reduces redness, itching & sensitivity. Prevents premature aging. SensAmone P5.

Description
About Us
Request A Quote

Description

Pentapeptide-59 Basic Chemical Information

Pentapeptide-59 Powder Specification

Pentapeptide-59 Solution Specification

The mechanism of Pentapeptide-59

Advantage and Benefit

FAQs

A:Pentapeptide-59 (RRRFV) targets the root cause of sensitive skin—overactive TRPV1 pain receptors—by blocking them with high selectivity. In vitro, it inhibits TRPV1 activation by 80%, outperforming the full‑length sea anemone protein. Placebo‑controlled studies confirm reduced itching, burning, redness, and skin reactivity.

A: Pentapeptide-59 is a synthetic peptide that mimics a sea anemone venom protein. It specifically binds to and inhibits the overactive TRPV1 pain receptor in the skin. By blocking this receptor, it neutralizes the signals that cause itching, stinging, and burning sensations, effectively calming reactive skin. In vitro studies show it inhibits TRPV1 activation by 80%.

A: TRPV1 receptors are overexpressed in photoaged skin, and their continuous activation upregulates enzymes that destroy collagen, leading to premature skin aging. By inhibiting this overactive TRPV1 receptor, Pentapeptide-59 helps break this chain of events, protecting the skin‘s collagen network and preventing the formation of premature wrinkles and other signs of aging.

A: Yes. Clinical studies on skin show that Pentapeptide-59 effectively reduces signs of sensitization, which includes a visibly noticeable reduction in skin redness. It accomplishes this by calming the skin‘s overreactive response to environmental triggers and minimizing the skin’s overall stress response, leading to a more even, less irritated complexion.

A: The full-length APHC1 protein is too large to penetrate skin and is unstable for cosmetic use. The synthetic Pentapeptide-59 solves this by being smaller and more stable. Research shows it is more effective than the full protein: Pentapeptide-59 inhibited TRPV1 receptor activation by 80%, while the full-length APHC1 achieved only 25% inhibition in the same molecular concentration.

GENOPEP GROUP | The Engine of Your Peptide Innovation

GENOPEP Group is a leading global peptide technology solutions provider, specializing in R&D, manufacturing, and commercialization in the fields of skin science and biopharmaceuticals. Supported by advanced scientific capabilities and a fully integrated supply chain, we deliver efficient and reliable innovation support to skincare brands worldwide.

We focus on three key service areas, empowering partners throughout the entire product lifecycle from concept to market:

  • Active Ingredients and Formulation Development – Grounded in cutting-edge research, we provide high-efficacy skincare ingredients, ingredient complexes, and complete formulation solutions.
  • End-to-End Production Support – Covering the full journey from lab-scale R&D and pilot optimization to commercial manufacturing, ensuring consistent product quality and reliable supply.
  • Custom Synthesis Services – With strong capabilities in novel molecule development, we specialize in the design, synthesis, and preparation of peptide-based novel ingredients and related reference standards.

We believe in technology-driven products and collaboration-driven value. GENOPEP is not just a supplier—we are your trusted innovation partner, dedicated to co-creating the next generation of skincare solutions with you.

REQUEST A QUOTE

REQUEST A QUOTE